Sysmex Corp (6869) – Strategy, SWOT and Corporate Finance Report
- Pages: 63
- Published: June 2023
- Report Code: MLME1016FSA
Sysmex Corp (6869) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include haematology, haemostasis, and urinalysis analyzers. It conducts research and development at its facilities in Japan, France, New Zealand, Germany and the US. The company operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa, and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.
Scope
• Detailed information on Sysmex Corp required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Sysmex Corp in the form of a SWOT analysis
• An in-depth view of the business model of Sysmex Corp including a breakdown and examination of key business segments
• News about Sysmex Corp, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Sysmex Corp and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Sysmex Corp as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Sysmex Corps business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Yagami Inc
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
Cytek Biosciences Inc
Bio-Rad Laboratories Inc
bioMerieux SA
Becton Dickinson and Co
Beckman Coulter Inc
Bayer Healthcare LLC, Diabetes Care Division
Alere Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.